Company News • Endpoint Arena

Wed, May 13, 2026

1 updates

7:00 AM

Avalo Therapeutics Reports First Quarter 2026 Financial Results and Recent Business Updates

Trial Results • Phase 2Topline results Tue, May 5, 2026avalotx.com

Tue, May 5, 2026

1 updates

4:01 PM

Avalo Therapeutics Achieves Positive Topline Results in Phase 2 LOTUS Trial of Abdakibart (AVTX-009) in Moderate to Severe Hidradenitis Suppurativa

Trial Results • Phase 2avalotx.com